ArticleThe Journal of investigative dermatology2019
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations.
Open access · greenAbstract read
In one paragraph
Article in The Journal of investigative dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 22 citations in OpenAlex.
- The Diagnostic Role of Skin Manifestations in Rheumatic Diseases in Children: A Critical Review of Paediatric Vasculitis.International journal of molecular sciences · 2024Review
- International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.The Journal of dermatology · 2024Article
- Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis.Vaccines · 2022Article
- Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis.International journal of women's dermatology · 2021Review
- The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.Annals of translational medicine · 2021Review
- Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model.Frontiers in pharmacology · 2020Article
- Review
- A double-blind, randomized, placebo-controlled, phase II trial of baricitinib for systemic lupus erythematosus: how to optimize lupus trials to examine effects on cutaneous lupus erythematosus.The British journal of dermatology · 2019Article
- Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.F1000Research · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 18 institutions in 7 countries.
Josef Symon S ConchaCorporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Aikaterini PatsatsiCorporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ann Marshak-RothsteinDivision of Rheumatology, Department of Medicine, University of Massachusetts School of Medicine, Worcester, Massachusetts, USA.
Ming-Lin LiuCorporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Animesh A SinhaDepartment of Dermatology, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Lela A LeeDepartments of Dermatology and Medicine, University of Colorado School of Medicine, Denver, Colorado, USA.
Joseph F MerolaDepartment of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ali JabbariDepartment of Dermatology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA; Interdisciplinary Program in Immunology, University of Iowa, Iowa City, Iowa, USA.
Johann E GudjonssonDepartment of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
François ChassetSorbonne Université, Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France.
Paul JarrettDepartment of Medicine, The University of Auckland, Auckland, New Zealand.
Benjamin ChongDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Lisa ArkinDepartments of Dermatology and Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Anthony P FernandezDepartments of Dermatology and Pathology, Cleveland Clinic, Cleveland, Ohio, USA.
Marzia CaproniDermatologic Rare Diseases and Skin Immunopathology Unit, USL Toscana Centro-University of Florence, Florence, Italy.
Steven A GreenbergDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Hee Joo KimDepartment of Dermatology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
David R PearsonCorporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alisa FemiaRonald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.
Ruth Ann VleugelsDepartment of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
David FiorentinoDepartment of Dermatology, Stanford University School of Medicine, Redwood City, California, USA.
Manabu FujimotoDepartment of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Joerg WenzelDepartment of Dermatology, University of Bonn, Bonn, Germany.
Victoria P WerthCorporal Michael J. Crescenz VAMC, Philadelphia, Pennsylvania, USA; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: werth@pennmedicine.upenn.edu.
Philadelphia VA Medical Center · USBrigham and Women's Hospital · USAzienda Usl Toscana Centro · ITCleveland Clinic · USGachon University · KRNew York University · USSorbonne Université · FRStanford University · USThe University of Texas Southwestern Medical Center · USUniversity at Buffalo, State University of New York · USUniversity of Auckland · NZUniversity of Bonn · DEUniversity of Colorado Denver · USUniversity of Iowa · USUniversity of Massachusetts Chan Medical School · USUniversity of Michigan · USUniversity of Tsukuba · JPUniversity of Wisconsin–Madison · US
Funding
Treatment of Dermatomyositis with Ajulemic Acid, a Non-Psychoactive CannabinoidR21AR066286 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI WERTH, VICTORIA P · 2014 to 2016
$387kThe role of TNF-Alpha in cutaneous integrityI01BX000706 · VA · PHILADELPHIA VA MEDICAL CENTER · PI WERTH, VICTORIA P · 2013 to 2016
–BLRD VA I01 BX000706NIAMS NIH HHS R21 AR066286
Abstract
PubMed holds no abstract for this paper.
Indexed as
Consensus Statements as TopicInternational CooperationConsensusDelphi TechniqueDermatologic AgentsDermatomyositisHumansLupus Erythematosus, CutaneousQuality of LifeSeverity of Illness IndexDermatologic Agents
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.